Increased risk of thyroid autoimmunity in rheumatoid arthritis

Endocrine

Volumn 50, Issue 1, 2015, Pages 4-5

  Feldt Rasmussen, Ulla ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; INFLIXIMAB; RITUXIMAB; TESTOSTERONE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; ANTIRHEUMATIC AGENT; AUTOANTIBODY;

ATROPHIC THYROIDITIS; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; ECHOGRAPHY; EDITORIAL; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THYROID DISEASE; THYROID FUNCTION; THYROIDITIS; THYROTROPIN BLOOD LEVEL; ADVERSE EFFECTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL THERAPY; BLOOD; COMORBIDITY; DRUG EFFECTS; FEMALE; MALE; RHEUMATIC DISEASES; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL THERAPY; COMORBIDITY; FEMALE; HUMANS; MALE; RHEUMATIC DISEASES; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 84940440388     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-015-0671-1     Document Type: Editorial

References (7)

1. P. Xi-Feng, G. Jian-Qiu, S. Zhong-Yan, Increased risk of thyroid autoimmunity in rheumatoid arthritis: a systematic review and meta-analysis. Endocrine (2015). doi:10.1007/s12020-015-0533-x
2. M. Kaklamanos, D. Thomas, D. Pikazis, G. Kaltsas, Thyroid-specific changes following treatment with biological therapies in patients with rheumatic diseases. Endocrine (2015). doi:10.1007/s12020-015-0551-8
3. W.A. Scherbaum, P.Y. Youinou, P. Le Goff, G.F. Bottazzo, Anti-perinuclear and rheumatoid factor in different forms of autoimmune thyroid disease. Clin. Exp. Immunol. 55, 516–518 (1984)
4. J.C. Mandac, S. Chaudhry, S.E. Sherman, Y. Tomer, The clinical and physiological spectrum of interferon-alpha induced thyroiditis:toward a new classification. Hepatology 43, 661–672 (2006)
5. A.J. Coles, M. Wing, S. Smith, F. Coraddu, S. Greer, C. Taylor, Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 354, 1691–1695 (1995). doi:10.1016/S0140-6736(99)02429-0
6. A. Hauschild, H. Gogas, A. Tarhini, M.R. Middleton, A. Testor, B. Dreno et al., Practical guidelines for the management of interferon-α-2b side effects in patients receiving adjuvant treatment for melanoma. Cancer 112, 982–994 (2008)
7. F. Torino, A. Barnabei, R.M. Paragliola, P. Marchetti, R. Salvatori, S.M. Corsello, Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. Eur. J. Endocrinol. 169, 153–164 (2013). doi:10.1530/EJE-13-0434